Speakers at CCC TRIO 2025 - Translational Research In Oncology
12th - 13th June 2025, Vienna, Hörsaalzentrum, Medical University of Vienna
1090 Vienna, Währinger Gürtel 18 - 20
Catherine Alix-Panabières, University Medical Centre of Montpellier (CHU)
Nicole Amberg, Department of Neuropathology and Neurochemistry, Medical University of Vienna/University Hospital Vienna
Hemma Bauer, Ministry of Science
Thomas Bauer, Center for Cancer Research, Medical University of Vienna
Tjalling Bosse, Leiden University Medical Center (LUMC)
Freddie Bray, The International Agency for Research on Cancer (IARC), Lyon
Stefanie Brezina, Center for Cancer Research, Medical University of Vienna
Michael Dengler, Division of Oncology, Medical University of Graz
Christina Dietscher, Ministry of Health
Helmut Dolznig, Institut of Medical Genetics, Medical University of Vienna
Gerhard Ecker, Department of Pharmaceutical Sciences, University of Vienna
Franziska Eckert, Department of Radiation Oncology, Medical University of Vienna/University Hospital Vienna
Bernhard Englinger, Department of Urology, Medical University of Vienna/University Hospital Vienna
Anna Fagotti, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome
David Fischer, Institute für Artificial Intelligence, Medical University of Vienna/University Hospital Vienna
Michaela Fritz, Vice-Rector Research, Medical University of Vienna
Johannes Gojo, Department of Pediatrics and Adolescence Medicine, Medical University of Vienna/University Hospital Vienna
Florian R. Greten, Georg Speyer Haus, Institute for Tumor Biology and Experimental Therapy
Ines Haberl, The Austrian Research Promotion Agency (FFG)
Nadia Hallwirth, Boehringer Ingelheim
Douglas Hanahan, Ludwig Institute for Cancer Research, Lausanne
Samantha Hasenleithner, Division of Oncology, Department of Internal Medicine, Medical University of Graz
Helmuth Haslacher, Clinical Department of Laboratory Medicine, Medical University of Vienna
Peter Hégyi, Centre for Translational Medicine & Division for Pancreatic Disorders, CVC, Semmelweis University, Budapest
Dietmar Herndler-Brandstetter, Center for Cancer Research, Medical University of Vienna
Philipp Hofer, Clinical Department of Pathology, Medical University of Vienna
Christoph Höller, Department of Dermatology, Medical University of Vienna/University Hospital Vienna
Lorenz Kadletz-Wanke, Department of Otorhinolaryngology, Medical University of Vienna/University Hospital Vienna
Lukas Kenner, Clinical Department of Pathology, Medical University of Vienna/University Hospital Vienna
Elisabeth Kernbauer-Hölzl, The Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG)
Anna Lämmerer, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna/University Hospital Vienna
Isaac Lazzeri, Division of Oncology, Department of Internal Medicine, Medical University of Graz
Lisa Mayr, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna
Zsolt Megyesfalvi, Department of Thoracic Surgery, Medical University of Vienna
Stefan Mereiter, Department of Laboratory Medicine, Medical University of Vienna/University Hospital Vienna
Antonia Müller, Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna/University Hospital Vienna
Eva Obermayr, Department of Obstetrics and Gynecology, Medical University of Vienna/University Hospital Vienna
Georg Pfeiler, Department of Gynecology, Medical University of Vienna/University Hospital Vienna
Thomas Powles, University of London, Barts Cancer Centre
Sazan Rasul, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna
Claas Röhl, Co-Founder NF Patients United
Maria Sibilia, Center for Cancer Research, Medical University of Vienna
Shahrokh Shariat, Department of Urology, Head Comprehensive Cancer Center Vienna, Medical University of Vienna/University Hospital Vienna
Victoria Stary, Department of General Surgery, Medical University of Vienna/University Hospital Vienna
Saverio Tardito, Center for Cancer Research, Medical University of Vienna
Thomas Vogl, Center for Cancer Research, Medical University Vienna
Dominik Wolf, Department of Oncology, Medical University of Innsbruck